Say Communications
Say Communications
7 Francis Grove
Wimbledon
London, SW19 4DW
United Kingdom
Homepage
News Feed
Say announces Synairgen's exciting breakthrough in severe flu treatment
Say announces Synairgen's exciting breakthrough in severe flu treatment
17/06/2010
Say publicises UK breakthrough from respiratory drug discovery and development company Synairgen.

Synairgen has developed a new flu drug that ‘switches on’ the lungs’ natural defences to flu and flu-like viruses, preventing the spread of infection from cell to cell even after infection has taken hold.  The development could have a significant impact on the treatment of both seasonal and pandemic flu, with potentially positive implications for patient outcome and the financial burden on the NHS.  The development was announced at the American Thoracic Society’s International Conference, with Say drafted in to transmit the information to UK print and online media.

For more information go to

www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=22101

Press Releases
img
18/06/2010
While most people look forward to the long warm summer months, anyone who suffers from hay fever may be less than enthusiastic. With 13 million people in Britain suffering from hay fever1, there is a real need for a simple and effective solution.
img
18/06/2010
While most young people look forward to the long warm summer months, anyone who suffers from hay fever may be less than enthusiastic at the combination of high pollen and end of year exams. With 25% of young people suffering from hay fever1, there is a real need for a simple and effective solution.
img
18/06/2010
Looking forward to getting away from it all but dreading the journey? Travel sickness is a common problem, especially among children, affecting 38% of 5-17 year olds1.
News Feed
Press Releases
Profile
We are an independent, award winning communications agency based in London.